Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function

被引:195
作者
Fuxe, K [1 ]
Ferré, S
Canals, M
Torvinen, M
Terasmaa, A
Marcellino, D
Goldberg, SR
Staines, W
Jacobsen, KX
Lluis, C
Woods, AS
Agnati, LF
Franco, R
机构
[1] Karolinska Inst, Dept Neurosci, Div Cellular & Mol Neurochem, Stockholm, Sweden
[2] Univ Barcelona, Dept Biochem & Mol Biol, E-08007 Barcelona, Spain
[3] Univ Ottawa, Ottawa, ON K1N 6N5, Canada
[4] NIDA, DHHS, NIH, Intramural Res Program, Baltimore, MD 21224 USA
[5] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy
关键词
adenosine A(2A) receptors; dopamine D-2 receptors; heteromers; Parkinson's disease; schizophrenia;
D O I
10.1385/JMN:26:2-3:209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The existence of A(2A)-D-2 heteromeric complexes is based on coimmunoprecipitation studies and on fluorescence resonance energy transfer and bioluminescence resonance energy transfer analyses. It has now become possible to show that A(2A) and D-2 receptors also coimmunoprecipitate in striatal tissue, giving evidence for the existence of A(2A)-D-2 heteromeric receptor complexes also in rat striatal tissue. The analysis gives evidence that these heteromers are constitutive, as they are observed in the absence of A(2A) and D-2 agonists. The A(2A)-D-2 heteromers, could either be A(2A)-D-2 heterodimers and/or higher-order A(2A)-D-2 hetero-oligomers. In striatal neurons there are probably A(2A)-D-2 heteromeric complexes, together with A(2A)-D-2 homomeric complexes in the neuronal surface membrane. Their stoichiometry in various microdomains will have a major role in determining A(2A) and D-2 signaling in the striatopallidal GABA neurons. Through the use of D-2/D-1 chimeras, evidence has been obtained that the fifth transmembrane (TM) domain and/or the I3 of the D2 receptor are part of the A(2A)-D-2 receptor interface, where electrostatic epitope-epitope interactions involving the N-terminal part of I3 of the D-2 receptor (arginine-rich epitope) play a major role, interacting with the carboxyl terminus of the A(2A) receptor. Computerized modeling of A(2A)-D-2 heteromers are in line with these findings. It seems likely that A(2A) receptor-induced reduction of D-2 receptor recognition, G protein coupling, and signaling, as well as the existence of A(2A)-D-2 co-trafficking, are the consequence of the existence of an A(2A)-D-2 receptor heteromer. The relevance of A(2A)-D-2 heteromeric receptor complexes for Parkinson's disease and schizophrenia is emphasized as well as for the treatment of these diseases. Finally, recent evidence for the existence of antagonistic A(2A)-D-3 heteromeric receptor complexes in cotransfected cell lines has been summarized.
引用
收藏
页码:209 / 219
页数:11
相关论文
共 58 条
[1]   Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons [J].
Agnati, LF ;
Ferré, S ;
Lluis, C ;
Franco, R ;
Fuxe, K .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :509-550
[2]  
AGNATI LF, 1980, MED BIOL, V58, P182
[3]   The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys [J].
Andersen, MB ;
Fuxe, K ;
Werge, T ;
Gerlach, J .
BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08) :639-644
[4]   Adenosine A2A receptor antagonist treatment of Parkinson's disease [J].
Bara-Jimenez, W ;
Sherzai, A ;
Dimitrova, T ;
Favit, A ;
Bibbiani, F ;
Gillespie, M ;
Morris, MJ ;
Mouradian, MM ;
Chase, TN .
NEUROLOGY, 2003, 61 (03) :293-296
[5]   Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch [J].
Bofill-Cardona, E ;
Kudlacek, O ;
Yang, Q ;
Ahorn, H ;
Freissmuth, M ;
Nanoff, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32672-32680
[6]   Adenosine A2A-dopamine D2 receptor-receptor heteromerization -: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer [J].
Canals, M ;
Marcellino, D ;
Fanelli, F ;
Ciruela, F ;
de Benedetti, P ;
Goldberg, SR ;
Neve, K ;
Fuxe, K ;
Agnati, LF ;
Woods, AS ;
Ferré, S ;
Lluis, C ;
Bouvier, M ;
Franco, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :46741-46749
[7]   Homodimerization of adenosine A2A receptors:: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer [J].
Canals, M ;
Burgueño, J ;
Marcellino, D ;
Cabello, N ;
Canela, EI ;
Mallol, J ;
Agnati, L ;
Ferré, S ;
Bouvier, M ;
Fuxe, K ;
Ciruela, F ;
Lluis, C ;
Franco, R .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (03) :726-734
[8]   Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization.: Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors [J].
Ciruela, F ;
Burgueño, J ;
Casadó, V ;
Canals, M ;
Marcellino, D ;
Goldberg, SR ;
Bader, M ;
Fuxe, K ;
Agnati, LF ;
Lluis, C ;
Franco, R ;
Ferré, S ;
Woods, AS .
ANALYTICAL CHEMISTRY, 2004, 76 (18) :5354-5363
[9]   Adenosine A(2A) receptors modulate the binding characteristics of dopamine D-2 receptors in stably cotransfected fibroblast cells [J].
Dasgupta, S ;
Ferre, S ;
Kull, B ;
Hedlund, PB ;
Finnman, UB ;
Ahlberg, S ;
Arenas, E ;
Fredholm, BB ;
Fuxe, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 316 (2-3) :325-331
[10]  
Díaz-Cabiale Z, 2001, NEUROREPORT, V12, P1831